艾美疫苗(06660.HK) 公布，拟向Factorial Master Fund配售1,550万股，占扩大后H股约3.05%及已发行股份数目约1.26%。每股作价5.01元，较昨日(27日)收市价6.26元折让约19.97%。
公司预期配售事项净集资约7,470万元，当中约60%将用于加速多个产品线中各项临床前及临床项目的研发，包括但不限于开展多区域临床试验，以及用于建设基础设施和相关设施；约20%用于新产品的研发、营销及商业化；约20%用于营运资金及其他企业用途。
公司相信，配售事项将有利于增强流动性和财务状况，扩大股东基础，优化资本结构，并支持公司的健康及可持续发展。(jl/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-27 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.